Nickel v. Unum Life Insurance Co. of America

582 F. Supp. 2d 869, 43 Employee Benefits Cas. (BNA) 2368, 2008 U.S. Dist. LEXIS 16777, 2008 WL 2048702
CourtDistrict Court, E.D. Michigan
DecidedMarch 3, 2008
Docket06-10476-BC
StatusPublished
Cited by1 cases

This text of 582 F. Supp. 2d 869 (Nickel v. Unum Life Insurance Co. of America) is published on Counsel Stack Legal Research, covering District Court, E.D. Michigan primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nickel v. Unum Life Insurance Co. of America, 582 F. Supp. 2d 869, 43 Employee Benefits Cas. (BNA) 2368, 2008 U.S. Dist. LEXIS 16777, 2008 WL 2048702 (E.D. Mich. 2008).

Opinion

OPINION AND ORDER GRANTING PLAINTIFF’S MOTION FOR JUDGMENT TO REVERSE ADMINISTRATOR’S DECISION, DENYING DEFENDANT’S MOTION FOR JUDGMENT AFFIRMING ERISA DETERMINATION, AND REMANDING THE MATTER TO THE PLAN ADMINISTRATOR FOR FURTHER DETERMINATION

THOMAS L. LUDINGTON, District Judge.

Plaintiff Karen Ecker Nickel (“Plaintiff’) elected to participate in a disability insurance plan, an employee welfare benefits plan under the Employee Retirement Income Security Act (ERISA), 29 U.S.C. §§ 1001, et seq., administrated by Defendant Unum Life Insurance Company of America (“Defendant”). According to Plaintiffs treating physicians, Plaintiff suffers from Chronic Fatigue Syndrome (“CFS”), Lyme disease, Epstein-Barr virus (“EBV”), cardiomyopathy, and a host of other illnesses. Defendant denied Plaintiffs claim for long-term disability benefits, determining that Plaintiffs medical records did not objectively establish that she was “disabled” under the definition of the plan. Plaintiff appealed, and Defendant reviewed and upheld its denial of benefits. Plaintiff seeks review of that decision in this Court. 29 U.S.C. § 1132(a)(1)(B). The Court has considered the parties’ submissions and now concludes that Defendant’s denial of benefits was arbitrary and capricious.

Although the cross motions were scheduled for hearing before this Court on February 14, 2008, the Court has reviewed the parties’ submissions and finds that the relevant law and facts have been set forth in *871 the briefs. The Court concludes that oral argument will not aid in the disposition of the motion. Accordingly, it is ORDERED that the motion be decided on the papers submitted. Compare E.D. Mich. LR 7.1(e)(2).

I

Plaintiff is a cytotechnologist at the Mid-Michigan Medical Center (“MMC”) in Midland, Michigan. Administrative Record (“AR”) at 17. Plaintiff worked as cyto-technologist at MMC from September 15, 1997 until January 22, 2004. Id. Plaintiff stopped working because she suffered from unusual fatigue and weakness, shortness of breath, chest pain, exhaustion, and an inability to move for extended periods of time. Plaintiff received short term disability benefits from January 30 until April 23, 2004. Id. Eventually, her treating physicians diagnosed Plaintiff with multiple illnesses, including CFS, EBY, Lyme disease, and cardiomyopathy. On March 22, 2004, Plaintiff submitted an application to Defendant for long term disability benefits. Id.

A cytotechnologist is a specialized lab technician that evaluates patient cell samples to identify particular types of cells and cellular abnormalities. According to a MMC job description, a cytotechnologist’s principal duties and responsibilities include “examining] patient slides for cancer and other abnormalities,” “coordinating] and maintaining] quality assurance,” “performing] special techniques,” and “entering] data and generating] reports.” AR at 21. MMC requires that a cytotech-nologist be able to lift twenty pounds, be dexterous “including handling, reaching, grasping, fingering, and feeling,” be able to handle multiple tasks and be able to freely move around the department and hospital. Id. “Typical working conditions” of a cytotechnologist at MMC includes “frequently [being] required to sit [or] stand for long periods of time.” Id.

Defendant provided MMC employees with group long term disability insurance. AR at 97. The policy provided that Defendant had “discretionary authority both to determine an employee’s eligibility for benefits and to construe the terms of [the] policy.” AR at 102. The policy defined “disability” and “disabled” as follows:

“Disability” and “disabled” mean that because of injury or sickness:

1. the insured cannot perform each of the material duties of his regular occupation; or
2. the insured, while unable to perform all of the material duties of his regular occupation on a full-time basis, is:
a. performing at least one of the material duties of his regular occupation or another occupation on a part-time or full-time basis; and
b. earning currently at least 20% less per month than his indexed pre-disability earnings due to that same injury or sickness.

AR at 107.

Plaintiffs claim form indicated that she first noticed symptoms in 2000 and sought treatment on September 29, 2003. AR at 30. She was unable to work due to her “insufficient” energy level and “worsening fatigue.” Id. Her illness prohibited her from performing physical activities, such as performing biopsies. Id.

Plaintiffs co-worker noticed a decline in Plaintiffs health and working abilities. AR at 232. She noticed that Plaintiff was “unable to perform with any consistency the basic functions of [a cytotechnologist]” and had difficulty walking down the hall or up stairs. AR at 232-33. Plaintiffs supervisor was concerned about Plaintiffs “extreme fatigue and tremors” and did not allow her to participate in morning biopsies. Id.; AR at 236.

*872 Plaintiffs primary physician was A. Martin Lerner, M.D. Dr. Lerner was the clinical professor of internal medicine at Wayne State University and a Governor of the American College of Physicians. AR at 587. Moreover, Dr. Lerner has coauthored multiple scholarly articles regarding the relationship between CFS and other illnesses, including EBV and car-diomyopathy. AR at 614-20, 621-26, 627-32, 633-59, 670-77, 678-91, 692-96, 697-703.

Dr. Lerner diagnosed Plaintiff with CFS, EBV, cardiomyopathy, thyroiditis, and Lyme disease. Plaintiff frequently sought medical care from Dr. Lerner during and after 2003. At Dr. Lerner’s request, Plaintiff underwent a series of tests at William Beaumont Hospital on October 17, 2003. AR at 63-65. One of those tests was a twelve minute exercise test on a “Bruce Protocol,” which indicated that Plaintiff reached 99% of her anticipated heart rate without cardiac complaints. AR at 64.

On October 23, 2003, Dr. Lerner opined that the results from a Hotter monitor were consistent with myocardial disease. AR at 361. He also discussed the prescription of Vattrex to “inhibit the multiplication of Epstein-Barr virus.” Id. On November 11, 2003, Dr. Lerner began Plaintiff on Vattrex. AR at 362. He described her energy index point score to be “barely” five out of a possible ten point scale. Id.

On January 23, 2004, Dr. Lerner noted that Plaintiff “does not look well” and is “really struggling.” AR at 360. He observed a “persistent” EBV infection, and an EBV-EA score of 79. Id. Plaintiff complained of lightheadedness, palpitations, and chest aches. Id. Dr. Lerner recommended that Plaintiff take six weeks off of work and continue to take Vattrex. Id.

On March 2, 2004, Dr. Lerner again noted “persistent” EBV infection and her “EBV-EA is a high positive, 82.” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Gillan v. Government Employees Insurance Co.
194 P.3d 1071 (Hawaii Supreme Court, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
582 F. Supp. 2d 869, 43 Employee Benefits Cas. (BNA) 2368, 2008 U.S. Dist. LEXIS 16777, 2008 WL 2048702, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nickel-v-unum-life-insurance-co-of-america-mied-2008.